As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.

Traveling can pose extra challenges for those with diabetes. Learn how to prepare, travel well, and stay safe on your trip.

Every year, millions of newborns—especially those born premature, underweight or sick—are at risk of neonatal hypoglycemia, a dangerous drop in blood sugar that can lead to seizures, brain injury and ...

Breakthroughs in optical sensing, like band-pass Raman spectroscopy, promise a future free from painful finger-prick blood ...

Now, a team at the Massachusetts Institute of Technology has taken a significant step towards true noninvasive glucose ...

Researchers at the Massachusetts Institute of Technology have created a compact Raman spectroscopy device that measures blood ...

Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Shining near-infrared light on a person’s skin helped scientists accurately track his blood glucose levels, offering a ...

MIT researchers developed a compact band-pass Raman spectroscopy device that noninvasively tracks glucose through the skin in ...

USA: MIT researchers have developed a noninvasive method to monitor glucose using Raman spectroscopy and have created a ...